3-196362528-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_015562.2(UBXN7):c.994G>A(p.Val332Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000328 in 1,614,022 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015562.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBXN7 | ENST00000296328.9 | c.994G>A | p.Val332Ile | missense_variant | 9/11 | 1 | NM_015562.2 | ENSP00000296328.4 | ||
UBXN7 | ENST00000428095.1 | c.508G>A | p.Val170Ile | missense_variant | 5/7 | 1 | ENSP00000397256.1 | |||
UBXN7 | ENST00000429160.1 | n.*618G>A | non_coding_transcript_exon_variant | 8/10 | 2 | ENSP00000397238.1 | ||||
UBXN7 | ENST00000429160.1 | n.*618G>A | 3_prime_UTR_variant | 8/10 | 2 | ENSP00000397238.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152128Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000321 AC: 8AN: 249492Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135354
GnomAD4 exome AF: 0.0000335 AC: 49AN: 1461894Hom.: 0 Cov.: 32 AF XY: 0.0000385 AC XY: 28AN XY: 727248
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152128Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74322
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 21, 2022 | The c.994G>A (p.V332I) alteration is located in exon 9 (coding exon 9) of the UBXN7 gene. This alteration results from a G to A substitution at nucleotide position 994, causing the valine (V) at amino acid position 332 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at